Role of glucose effectiveness in the determination of glucose tolerance

Diabetes Care

Volumn 19, Issue 9, 1996, Pages 1018-1030

  Best, James D ^a   Kahn, Steven E ^b   Ader, Marilyn ^c   Watanabe, Richard M ^c   Ni, Ta Chen ^c   Bergman, Richard N ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Veterans Affairs Puget Sound   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0029761076     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.9.1018     Document Type: Review

References (102)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
2. Cerasi E, Luft R: "What is inherited-what is added" hypothesis for the pathogenesis of diabetes mellitus. Diabetes 16: 615-627, 1967
3. Perley M, Kipnis DM: Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 15:867-874, 1966
4. Reaven GM, Bernstein R, Davis B, Olefsky JM: Nonketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med 60:80-88, 1976
5. Turner RC, Holman RR, Matthews D, Hockaday TDR, Peto J: Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28:1086-1096, 1979
6. Weir GC: Non-insulin dependent diabetes mellitus: interplay between β-cell inadequacy and insulin resistance. Am J Med 73:461-464, 1982
7. DeFronzo RA: The triumvirate: β-cell, muscle, liver: a collusion responsible for NlDDM. Diabetes 37:667-687, 1987
8. Cahill GF Jr: Beta-cell deficiency, insulin resistance or both? N Engl J Med 318: 1268-1270, 1991
9. Porte D Jr: β-cells in type II diabetes mellitus (Banting Lecture). Diabetes 40:166-180, 1991
10. Heine RJ, Manning I, Morgan L, Alberti KGMM: The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care 6:441-445, 1983
11. Nauck M, Stockmann F, Eben R, Creutzfeldt W: Reduced incretin effect in type 2 (non-insulm-dependent) diabetes. Diabetologia 29:46-52, 1986
12. Bergman RN: Toward physiological understanding of glucose tolerance: minimal-model approach (Lilly Lecture). Diabetes 38:1512-1527, 1989
13. Osei K: Predicting type II diabetes in persons at risk. Ann Intern Med 113:905-907, 1990
14. Rudenski AS, Matthews DR, Levy JC, Turner RC: Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40:908-917, 1991
15. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
16. Soskin S, Allweiss MD, Cohn DJ: Influence of the pancreas and the liver upon the dextrose tolerance test. Am J Physiol 109:155-165, 1934
17. Vranic M, Fono P, Kovacevic N, Lin BJ: Glucose kinetics and fatty acids in dogs on matched insulin infusion after glucose load. Metabolism 20:954-967, 1971
18. Ader M, Pacini G, Yang YJ, Bergman RN: Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal model prediction with direct measurements. Diabetes 34:1092-1103, 1985
19. Best JD, Taborsky GJ Jr, Halter JB, Porte D Jr: Glucose disposal is not proportional to plasma glucose level in man. Diabetes 30:847-850, 1981
20. Verdonk CA, Rizza RA, Gerich JE: Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes 30:535-537, 1981
21. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
22. DeFronzo RA, Ferrannini E: Influence of plasma glucose and insulin concentration on plasma glucose clearance in man. Diabetes 31:683-688, 1982
23. Gottesman I, Mandarino L, Verdonk C, Rizza R, Gerich J: Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man. J Clin Invest 70:1310-1314, 1982
24. Proietto J, Nankervis A, Aitken P, Caruso G, Harewood M, Alford FP: The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucose. Metabolism 32:1022-1028, 1983
25. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM: Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 76:1782-1788, 1985
26. Hansen IL, Cryer PE, Rizza RA: Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects. Diabetes 34:751-755, 1985
27. 14C]glucose. Diabetes 35:642-648, 1986
28. Fink RI, Wallace P, Olefsky JM: Effects of aging on glucose-mediated glucose disposal and glucose transport. J Clin Invest 77:2034-2041, 1986
29. Yki-Jarvinen H, Bogardus C, Howard BV: Hyperglycemia stimulates carbohydrate oxidation in humans. Am J Physiol 253:E376-E382, 1987
30. Arnfred J, Schmitz O, Hother-Nielsen O, Orskov C, Beck-Nielsen H, Hermansen K, Christiansen JS, Alberti KGMM, Orskov H: Marked impairment of the effect of hyperglycemia on glucose uptake and glucose production in insulin-dependent diabetes. Diabetic Med 5:755-760, 1988
31. Thorburn AW, Gumbiner B, Brechtel G, Henry RR: Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes 39:22-30, 1990
32. Edelman SV, Laakso M, Wallace P, Brechtel G, Olefsky JM, Baron AD: Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes 39:955-964, 1990
33. Davis BM, Bernstein R, Kolterman O, Olefsky JM, Reaven GM: Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes 28:32-34, 1979
34. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrine Rev 6:45-86, 1985
35. Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R: A model of the kinetics of insulin in man. J Clin Invest 53:1481-1492, 1974
36. Doberne L, Greenfield MS, Schulz B, Reaven GM: Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes 30:829-835, 1981
37. Yang YJ, Hope ID, Ader M, Bergman RN: Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84:1620-1628, 1989
38. Ader M, Poulin RA, Yang YJ, Bergman RN: Dose response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of pe-ripheral tissues. Diabetes 41:241-253, 1992
39. Poulin RA, Steil GM, Moore DM, Ader M, Bergman RN: Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes 43:180-190, 1994
40. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S: Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93:10-16, 1994
41. Bergman RN, Ni T-C, Ader M: Glucose effectiveness. In Clinical Research in Diabetes. Draznin B, Rizza RA, Eds. Totowa, NJ, Humana, 1996
42. Prager R, Wallace P, Olefsky JM: In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78:472-481, 1986
43. Sacca L, Hendler R, Sherwin RS: Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab 47:1160-1163, 1978
44. Liljenquist JE, Mueller GL, Cherrington AD, Perry JM, Rabinowitz D: Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endocrinol Metab 48:171-175, 1979
45. Altszuler N, Steele R, Wall JS, Dunn A, deBodo RC: Effect of growth hormone on carbohydrate metabolism in normal and hypophysectomized dogs, studies with C-14-giucose. Am J Physiol 196: 121-124, 1959
46. Caviezel F, Caltaneo AG, Marini G, Pozza G, Capani F, Sensi S: Diurnal rhythm of blood glucose and insulin levels in obese subjects with or without impaired glucose tolerance. In Recent Advances in Obesity and Diabetes Research. Melchionda N, Ed. New York, Raven, 1984, p. 49-54
47. Cherrington AD, Williams PE, Harris MS: Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism 27:787-791, 1978
48. Adkins BA, Myers SR, Hendrick GK, Stevenson RVV, Williams PE, Cherrington AD: Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest 79:557-565, 1987
49. Ader M, Bergman RN: Experimental dissection of metabolic processes accounting for glucose-dependent glucose disappearance (Abstract), J Invest Med 43: 170A, 1995
50. Christopher MJ, Rantzau C, Ward GM, Alford FP: Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am J Physiol 268:E410-E421, 1995
51. Kahn SE, Larson VG, Schwartz RS, Beard JC, Cain KC, Fellingham GW, Stratton JR, Cerqueira MD, Abrass IB: Exercise training delineates the importance of β-cell dysfunction to the glucose intolerance of human aging. J Clin Endocrinol Metab 74:1336-1342, 1992
52. Brun JF, Guintrand-Hugret R, Boegner C, Bouix O, Orsetti A: Influence of short-term submaximal exercise on parameters of glucose assimilation analyzed with the minimal model. Metabolism 44: 833-840, 1995
53. Tokuyama K, Higaki Y, Fujitani J, Kiyonaga A, Tanaka H, Shindo M, Fukushima M, Nakai Y, Imura H, Nagata I, Taniguchi A: Intravenous glucose tolerance test-derived glucose effectiveness in physically trained humans. Am J Physiol 265:E298-E303, 1993
54. D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW: Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest 93:2263-2266, 1994
55. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwanz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Pone D Jr: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43:587-592, 1994
56. Falcone T, Little AB, Morris D: Impaired glucose effectiveness in patients with polycystic ovary syndrome. Human Reprod 7:922-925, 1992
57. Caumo A, Giacca A, Morgese M, Pozza G, Micossi P, Cobelli C: Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabetic Med 8:822-832, 1991
58. Piccardo MG, Pacini G, Rosa M, Vichi R: Insulin resistance in myotonic dystrophy. Enzyme 45:14-22, 1991
59. Pestell R, Alford F, Ramos R, Sawyer S, Best J, Ward G: Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: a minimal model analysis. Clin Endocrinol 33: 481-493, 1990
60. Walton C, Godsland IF, Proudler AJ, Felton C, Wynn V: Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol 262:E755-E762, 1992
61. Ward GM, Walters JM, Aitken PM, Best JD, Alford FP: Effects of prolonged pulsatile hyperinsulinemia in humans: enhancement of insulin sensitivity. Diabetes 39:501-507, 1990
62. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
63. Finegood DT, Hramiak IM, Dupre J: A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549, 1990
64. Osei K, Cottrell DA, Henry ML, Tesi RJ, Ferguson RM, O'Dorisio TM: Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in type 1 (insulin-dependent) diabetic pancreas allograft recipients. Diabetologia 35:676-680, 1992
65. Kabn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr: Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic-acid-induced insulin resistance. Diabetes 38:562-568, 1989
66. Kahn SE, Klaff LJ, Schwanz MW, Beard JC, Bergman RN, Taborsky GJ Jr, Porte D Jr: Treatment with a somatostatin analog decreases pancreatic β-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 71:994-1002, 1990
67. Kahn SE, Bergman RN, Schwanz MW, Taborsky GJ Jr, Porte D Jr: Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. Am J Physiol 262:E518-E523, 1992
68. Marchesini G, Pacini G, Bianchi G, Patrono D, Cobelli C: Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 99:1715-1722, 1990
69. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R: Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol 37:147-155, 1992
70. Ward GM, Weber KM, Walters IM, Aitken PM, Lee B, Best JD, Boston RC, Alford FP: A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes. Metabolism 40: 4-9, 1991
71. Marangou AG, Weber KM, Boston RC, Aitken PM, Heggie JCP, Kirsner RLG, Best JD, Alford FP: Metabolic consequences of prolonged hyperinsulinemia in humans: evidence for induction of insulin insensitivity. Diabetes 35:1383-1389, 1986
72. Marangou AG, Alford FP, Ward G, Liskaser F, Aitken PM, Weber KM, Boston RC, Best JD: Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 37:885-891, 1988
73. Christiansen E, Tibell A, Volund A, Rasmussen K, Tyden G, Pedersen O, Christensen NJ, Madsbad S: Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients. J Clin Endocrinol Metab 79:1561-1569, 1994
74. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
75. Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR: Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes 42: 1635-1641, 1993
76. Kruszynska YT, Harry DS, Bergman RN, McIntyre N: Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia 36:121-128, 1993
77. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NlDDM. Diabetes 41:1540-1546, 1992
78. Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K: Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. Metabolism 42: 1164-1168, 1993
79. Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R: β-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41:1304-1312, 1992
80. Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagata I, Florant GL, Tokuyama K: Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis. Metabolism 43:714-718, 1994
81. Watanabe RM, Azen CG, Roy S, Perlman JA, Bergman RN: Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. J Clin Endocrinol Metab 79:1277-1283, 1994
82. Nakai Y, Taniguchi A, Fukushima M, Kawamura H, Morita T, Imura H, Nagata I, Tokuyama K: Insulin sensitivity during very-low-calorie diets assessed by minimal modeling. Am J Clin Nutr 56: 179S-181S, 1992
83. Tobin BL, DT Finegood: Reduced insulin secretion by repeated low doses of STZ impairs glucose effectiveness but does not induce insulin resistance in dogs. Diabetes 42:474-483, 1993
84. Ader M, RN Bergman: Marked diminution in glucose effectiveness contributes to glucose intolerance in experimental diabetes (Abstract). Diabetologia 36:A147, 1993
85. Finegood DT, Tzur D: Estimation of glucose effectiveness by the minimal model is dependent on the endogenous insulin secretory response (Abstract). Diabetes 44:192A, 1995
86. Mueckler M: Family of glucose-transporter genes: implications for glucose homeostasis and diabetes. Diabetes 39: 6-11, 1990
87. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S: Molecular biology of mammalian glucose transporters. Diabetes Care 13:198-208, 1990
88. Carruthers A: Facilitated diffusion of glucose. Physiol Rev 70:1135-1176, 1990
89. Crone C: Facilitated transfer of glucose from blood into brain tissue. J Physiol 181:103-113, 1965
90. Lang CH: Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in diabetic rats. Proc Soc Exp Biol Med 199:81-89, 1992
91. Printz RL, Magnuson MA, Granner DK: Mammalian glucokinase. Ann Rev Nutr 13:463-496, 1993
92. Meglasson MD, Matschinsky FM: Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 2:163-214, 1986
93. 12 myotubes and rat skeletal muscle. Diabetes 44:646-651, 1995
94. 2+-dependent mechanism. Diabetes 44:1345-1348, 1995
95. Bucolo RJ, Bergman RN, Marsh DJ, Yates FE: Dynamics of glucose autoregulation in the isolated, blood-perfused canine liver. Am J Physiol 227: 209-217, 1974
96. Bergman RN, Bucolo RJ: Interaction of insulin and glucose in the control of hepatic glucose balance. Am J Physiol 227: 1314-1322, 1974
97. Ruderman NB, Herrera MG: Glucose regulation of hepatic gluconeogenesis. Am J Physiol 214:1346-1351, 1968
98. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
99. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
100. Reaven GM, Miller R: Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17:560-569, 1968
101. Ader M, Bergman RN: Experimental dissection of metabolic processes accounting for glucose-dependent glucose disappearance (Abstract). J Invest Med 43: 170A, 1995
102. Ader M, Bergman RN: Evidence that "autoregulation" of hepatic glucose output is mediated by free fatty acids (Abstract). Diabetes 45:245A, 1996